Effects of Lactobacillus Plantarum KABP-51 Probiotic on Body Composition, Microbiome and Mood in Healthy Overweight Adults
Effects of Kaneka KABP-51 Probiotic on Mood, Metabolism, Microbiome, and Body Composition in Healthy Adults
1 other identifier
interventional
60
1 country
1
Brief Summary
The objective of this study is to recruit 60 healthy moderately overweight subjects to participate in a research study investigating the effects of a specific probiotic strain (Lactobacillus plantarum KABP-51) on measures of psychological mood state, gut microbiome status, stress hormones, and body composition (body fat and muscle mass). Our subjects will be measured 4 times over the course of a 12-week supplementation period - at Baseline, Week 4, Week 8, and Week 12. We will have 2 groups (N=30 per group):
- Probiotic Lactobacillus plantarum KABP-51
- Placebo (maltodextrin/corn starch) Subjects will be recruited from local fitness/wellness centers and businesses (e.g. Plymouth Fitness; Planet Fitness; Marathon Sports, etc) using a simple flyer. If volunteers meet the inclusion/exclusion criteria, they will review/sign the Informed Consent Form (ICF) before any Baseline measurements are collected. Participants will meet weekly (via online webinar) for educational sessions on nutrition, exercise, sleep, stress, and related healthy lifestyle topics. This periodic contact is extremely effective for maintaining compliance with the supplementation regimen and reducing dropouts. Our expectation is that this fairly simple 12-week design will show that the KABP-51 probiotic strain can support a variety of psychological benefits such as reduced stress and improved mood; as well as physical benefits such as improved stress hormone exposure and microbiome balance - all of which may lead to improved body composition (lower body fat and improved muscle mass).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2023
CompletedFirst Submitted
Initial submission to the registry
January 29, 2025
CompletedFirst Posted
Study publicly available on registry
February 5, 2025
CompletedFebruary 5, 2025
January 1, 2025
5 months
January 29, 2025
January 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Body Weight
12 weeks
Secondary Outcomes (2)
Microbiome Balance
12 weeks
Mood State
12 weeks
Study Arms (2)
Probiotic
EXPERIMENTALLactobacillus plantarum KABP-51; 1-billion CFU
Placebo
PLACEBO COMPARATORMaltodextrin
Interventions
Eligibility Criteria
You may qualify if:
- healthy moderately overweight
You may not qualify if:
- Pregnant women
- Inability to complete prescribed supplement regimen
- Current use of incompatible medications or supplements (weight loss, mood support, or blood sugar balance)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- 3 Waves Wellnesslead
- Kaneka Americas Holding Inc.collaborator
Study Sites (1)
3Waves Wellness
Plymouth, Massachusetts, 02360, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Scientist
Study Record Dates
First Submitted
January 29, 2025
First Posted
February 5, 2025
Study Start
February 14, 2023
Primary Completion
July 15, 2023
Study Completion
October 15, 2023
Last Updated
February 5, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share